You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Overview

  • Product nameAnti-RNF35 antibodySee all RNF35 primary antibodies ...
  • Description
    Mouse polyclonal to RNF35
  • Tested applicationsWB, ICC/IF more details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Full length Human RNF35 protein (AAH60785.1)

  • Positive controlK562 cell lysate, RNF35 transfected 293T cell lysate and HeLa cells

Properties

Applications

Our Abpromise guarantee covers the use of ab88109 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Notes
WB WB: Use a concentration of 1 µg/ml. Predicted molecular weight: 29 kDa.
ICC/IF ICC/IF: Use a concentration of 10 µg/ml.

Target

  • Alternative names
      Gm319 antibodyGm35 antibodyGm865 antibody
      Probable E3 NEDD8 protein ligase antibodyRING finger protein 35 antibodyring finger protein 40 antibodyRing finger RNF35 antibodyTRIM40 antibodyTripartite motif containing 40 antibodyTripartite motif containing protein 40 antibodyTripartite motif protein 40 antibody
    see all

Anti-RNF35 antibody images

  • Anti-RNF35 antibody (ab88109) at 1 µg/ml + K562 cell lysate at 50 µg

    Predicted band size : 29 kDa
  • All lanes : Anti-RNF35 antibody (ab88109) at 1 µg/ml

    Lane 1 : RNF35 transfected 293T cell lysate
    Lane 2 : Non-transfected 293T cell lysate

    Lysates/proteins at 25 µg per lane.


    Predicted band size : 29 kDa
  • ab88109 at 10µg/ml staining RNF35 in HeLa cells by Immunofluorescence.

References for Anti-RNF35 antibody (ab88109)

ab88109 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab88109.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"